Phase II study of the combination of Oxaliplatin and 5FU(mFOLFOX6) in patients with unresectable advanced/recurrent small intestinal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: mFOLFOX6 Primary outcome(s): Progression-Free rate Study Design: Single arm Non-randomized
创建时间：
2010-03-15
